Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies.
Skeate JG, Pomeroy EJ, Slipek NJ, Jones BJ, Wick BJ, Chang JW, Lahr WS, Stelljes EM, Patrinostro X, Barnes B, Zarecki T, Krueger JB, Bridge JE, Robbins GM, McCormick MD, Leerar JR, Wenzel KT, Hornberger KM, Walker K, Smedley D, Largaespada DA, Otto N, Webber BR, Moriarity BS.
Skeate JG, et al. Among authors: jones bj.
Mol Ther. 2024 Apr 15:S1525-0016(24)00241-7. doi: 10.1016/j.ymthe.2024.04.024. Online ahead of print.
Mol Ther. 2024.
PMID: 38627969